FDA: Diabetes drug Actos linked to bladder cancer
Links shared publicly online about this topic.
- 862total visits
FDA: Diabetes drug Actos linked to bladder cancer
View full resource at healthcare.tweetmeme.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Urinary System, Drug, FDA, Actos
Most Recently Shared on September 19, 2010 at 9:52 am By:
FDA: Diabetes drug Actos linked to bladder cancer http://retwt.me/1OQbw (via @wisdeo)
Actos Bladder Cancer Link (Pioglitazone) - Actos Diabetes Cancer Lawsuit
actosinjurylawyers.com — “Actos has been linked to bladder cancer in multiple studies and thus has drawn an FDA warning. If you've been diagnosed with bladder cancer speak with our attorneys immediately. Compensation may be available.” View full resource at actosinjurylawyers.com
Most Recently Shared on September 13, 2011 at 12:30 pm By:
FDA OKs stronger warning for diabetes drug pioglitazone - Related Stories - AANP SmartBrief
smartbrief.com — “The FDA authorized an updated label for diabetes medicines containing pioglitazone, such as Takeda Pharmaceutical's Actos, that includes data on increased risk of bladder cancer in patients treated for more than one year. Also, clinicians are advised against giving such drugs to patients with activ…” View full resource at smartbrief.com
Most Recently Shared on August 8, 2011 at 4:14 pm By:
#FDA OKs stronger #warning for #diabetes drug pioglitazone http://t.co/FzFVw6v #endo
Medical News: Pioglitazone Gets New Cancer Risk Labeling - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “Following a warning about bladder cancer risk, the FDA has approved updated label information for pioglitazone (Actos) and medications that contain it.” View full resource at medpagetoday.com
Most Recently Shared on August 5, 2011 at 8:49 pm By:
Pioglitazone Gets New Cancer Risk Labeling http://bit.ly/rni8ws
Medical News: Pioglitazone Gets New Cancer Risk Labeling - in Endocrinology, Diabetes from MedPage Today
medpagetoday.com — “Following a warning about bladder cancer risk, the FDA has approved updated label information for pioglitazone (Actos) and medications that contain it.” View full resource at medpagetoday.com
Most Recently Shared on August 5, 2011 at 8:47 pm By:
Pioglitazone Gets New Cancer Risk Labeling http://bit.ly/rhlnZi
Diabetes Drug May Increase Cancer Risk, FDA Says | ThirdAge
thirdage.com — “A diabetes drug currently under development may be linked to bladder and breast cancer, the U.S. Food and Drug Administration says.” View full resource at thirdage.com
Most Recently Shared on July 21, 2011 at 11:25 am By:
Diabetes Drug May Increase Cancer Risk, FDA Says http://bit.ly/oZNIqM
FDA: Diabetes Drug May up Cancer Risk - Drugs.com MedNews
drugs.com — “From UPI Health News (Business) (July 16, 2011) A diabetes drug under development may be linked to bladder and breast cancer, the U.S. Food and Drug Administrat” View full resource at drugs.com
Most Recently Shared on July 18, 2011 at 1:20 pm By:
FDA: Diabetes Drug May up Cancer Risk: From UPI Health News (Business) (July 16, 2011) A diabetes drug un... http://bit.ly/qVLPx6 #drug
Medical News: ADA: FDA Unlikely to Zap Pioglitazone - in Meeting Coverage, ADA from MedPage Today
medpagetoday.com — “SAN DIEGO -- Bladder cancer risks aren't likely to send the diabetes drug pioglitazone (Actos) down the same path as rosiglitazone (Avandia), according to this exclusive InFocus report from the Americ” View full resource at medpagetoday.com
Most Recently Shared on June 26, 2011 at 8:54 pm By:
ADA: FDA Unlikely to Zap Pioglitazone (with video) http://bit.ly/iy2WkY
Warning: Actos, a diabetes drug, is a potential link to bladder cancer. « Dr. Neil Baum's Urology Blog
neilbaum.wordpress.com — “Warning: Actos, a diabetes drug, is a potential link to bladder cancer. « Dr. Neil Baum's Urology Blog” View full resource at neilbaum.wordpress.com
Most Recently Shared on June 24, 2011 at 2:34 am By:
Warning: Actos, a diabetes drug, is a potential link to bladder cancer. http://wp.me/pKEtB-b5
Medical Societies Respond to the FDA’s Safety Announcement on the Use of the Diabetes Medication Actos (pioglitazone) - American Diabetes Association
t.co — “Diabetes leaders today are responding to the announcement made by the U.S. Food and Drug Administration (FDA) yesterday that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” View full resource at t.co
Most Recently Shared on June 20, 2011 at 3:59 pm By:
RT @HopeWarsha Response to FDA's 6/15 statement on Actos from ADA, Endo Society & AACE http://t.co/rArN4rc. Nice to see one clear message!
Medical Societies Respond to the FDA’s Safety Announcement on the Use of the Diabetes Medication Actos (pioglitazone) - American Diabetes Association
diabetes.org — “Diabetes leaders today are responding to the announcement made by the U.S. Food and Drug Administration (FDA) yesterday that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.” View full resource at diabetes.org
Most Recently Shared on June 20, 2011 at 3:56 pm By:
Combined response to FDA's 6/15 statement on Actos from ADA, Endo Society and AACE http://bit.ly/mLk1bq. How nice to see one clear message!
Diabetes Drug Actos May Raise Risk for Bladder C... ( By Steven Reinberg HealthDay Rep...)
bio-medicine.org — “Health, By Steven Reinberg HealthDay Reporter ...THURSDAY June 16 (HealthDay News) -- The U.S. Food and Drug Administr...The agency's warning comes five days after Germany and France pulled A...The new cancer warning will appear on the labeling the FDA said. ...However although Actos does have some side effects the beneficial e...,Diabetes,Drug,Actos,May,Raise,Risk,for,Bladder,Cancer:,FDA,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine new” View full resource at bio-medicine.org
Most Recently Shared on June 18, 2011 at 1:14 pm By:
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA http://bit.ly/iuGELw
FDA, medical societies warn of possible link between diabetes drug, bladder cancer risk | HemOncToday
hemonctoday.com — “After reviewing data from a 5-year interim analysis of an ongoing, 10-year epidemiological study, the FDA is informing the public of a possible” View full resource at hemonctoday.com
Most Recently Shared on June 17, 2011 at 7:51 pm By:
#FDA, medical societies warn of possible link between #diabetes drug, bladder cancer risk http://t.co/aHMiBBC
Medical societies respond to the FDA's safety announcement on the use of Actos
medicalxpress.com — “Diabetes leaders today are responding to the announcement made by the U.S. Food and Drug Administration (FDA) yesterday that the use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. According to the FDA's Safety Announcement, ...” View full resource at medicalxpress.com
Most Recently Shared on June 16, 2011 at 9:07 pm By:
Medical societies respond to the FDA's safety announcement on the use of Actos http://tw.medicalxpress.com/227462846
Prolonged Use of Diabetes Drug Actos May Increase Risk of Bladder Cancer
onclive.com — “The FDA announced that the prolonged use of pioglitazone (Actos) for more than 1 year has been linked to an increased risk of bladder cancer” View full resource at onclive.com
Most Recently Shared on June 16, 2011 at 9:02 pm By:
FDA Announces That Prolonged Use of Diabetes Drug Actos May Increase Risk of Bladder Cancer http://t.co/yQGYUHv
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA - Drugs.com MedNews
drugs.com — “The U.S. Food and Drug Administration is warning consumers that the popular diabetes drug Actos (pioglitazone) may increase the risk of bladder cancer when used” View full resource at drugs.com
Most Recently Shared on June 16, 2011 at 7:57 pm By:
Diabetes Drug Actos May Raise Risk for Bladder Cancer: FDA - http://bit.ly/iHvLaF
Advertisement

